- Filed
- Apr 22, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 18, 2025 | 238.97M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.09B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.09B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $606.43M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $608.27M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $344.57M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $304.49M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.28B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.27B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $3.44B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.41B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $720.49M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $721.46M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $7.38B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $7.35B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 242.41M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $19.41M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $331.93M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $3.83B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $3.77B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.38 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.38 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $43.94M |
| Net Income | Q1 2025 · Mar 31, 2024 | $92.14M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $31.6M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $595.83M |